RayKnowChina Research Map
Shortlist

Cancer

Pancreatic cancer in Hangzhou

杭州 胰腺癌

All diseases in Hangzhou

9 hospitals in Hangzhou

Order: papers led on pancreatic cancer, 2021–2025, then A–Z. Research activity, not a rating of care.

Only hospitals listed for pancreatic cancer: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Hangzhou may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.

  1. 115 papers led
  2. 66 papers led
  3. 53 papers led
  4. 29 papers led
    No open trial led
  5. 23 papers led
  6. 23 papers led
  7. 7 papers led
    No open trial led
  8. 6 papers led
    No open trial led
  9. 1 paper led

Pancreatic cancer in every city Hangzhou on the disease page, with the national map

47

open trials on pancreatic cancer with a hospital in Hangzhou

Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 18 Nov 2026, with a listed hospital in Hangzhou as lead sponsor or study site. 26 of them are led by a hospital in Hangzhou. Check the registry for the current status. Whether someone can take part is decided by the study team.

Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.

  1. Recruiting
    HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
    Phase
    Phase 2
    Started
    2026-02
    Posted
    Registry
    NCT07240766

    Age 18 years to 75 years (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  2. Recruiting
    Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
    Phase
    Phase 1/Phase 2
    Started
    2026-01
    Posted
    Registry
    NCT07435038

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteHangzhou

  3. Recruiting
    IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
    Phase
    Phase 2
    Started
    2026-04
    Posted
    Registry
    NCT07483554

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteHangzhou

  4. Recruiting
    Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
    Phase
    Phase 1/Phase 2
    Started
    2026-07
    Posted
    Registry
    NCT07640295

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 12 listed hospitals as study sitesBeijing, Changsha, Hangzhou, Harbin, Nanjing, Shanghai, Taiyuan, Wuhan, Zhengzhou

  5. Recruiting
    A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
    Phase
    Phase 1/Phase 2
    Started
    2026-09
    Posted
    Registry
    NCT07678593

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 9 listed hospitals as study sitesBeijing, Chengdu, Guangzhou, Hangzhou, Shanghai, Shenyang, Wuhan, Xi'an, Zhengzhou

  6. Recruiting
    IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
    Phase
    Phase 2
    Started
    2025-04
    Posted
    Registry
    NCT06770439

    Age 18 years to Not stated (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  7. Recruiting
    HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients
    Phase
    Phase 2
    Started
    2025-03
    Posted
    Registry
    NCT06770452

    Age 18 years to 75 years (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  8. Recruiting
    A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
    Phase
    Phase 3
    Started
    2025-06
    Posted
    Registry
    NCT06953999

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesHangzhou, Harbin, Shanghai

  9. Recruiting
    A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
    Phase
    Phase 2/Phase 3
    Started
    2025-10
    Posted
    Registry
    NCT06989437

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Dalian, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Lanzhou, Shanghai, Taiyuan, Wenzhou, Xi'an, Zhengzhou

  10. Recruiting
    Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
    Phase
    Phase 2
    Started
    2025-05
    Posted
    Registry
    NCT07006077

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteHangzhou

  11. Recruiting
    Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution
    Phase
    Not given
    Started
    2025-05
    Posted
    Registry
    NCT07034339

    Age 18 years to 80 years (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  12. Recruiting
    A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
    Phase
    Phase 1
    Started
    2025-07
    Posted
    Registry
    NCT07066657

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 8 listed hospitals as study sitesBeijing, Changsha, Hangzhou, Harbin, Shanghai, Wuhan, Zhengzhou

  13. Recruiting
    Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer
    Phase
    Phase 3
    Started
    2025-11
    Posted
    Registry
    NCT07235930

    Age 18 years to 75 years (registered criteria)

    Led by Zhejiang Cancer HospitalHangzhou

  14. Recruiting
    A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
    Phase
    Phase 2
    Started
    2025-12
    Posted
    Registry
    NCT07255404

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 11 listed hospitals as study sitesBeijing, Chengdu, Guangzhou, Hangzhou, Kunming, Nanchang, Shanghai, Shenyang, Wuhan, Zhengzhou

  15. Recruiting
    LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
    Phase
    Phase 1/Phase 2
    Started
    2025-09
    Posted
    Registry
    NCT07312422

    Age 18 years to 75 years (registered criteria)

    Led by Zhejiang Provincial People's HospitalHangzhou

  16. Recruiting
    Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
    Phase
    Not given
    Started
    2025-11
    Posted
    Registry
    NCT07359586

    Age not stated (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  17. Recruiting
    IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
    Phase
    Phase 1/Phase 2
    Started
    2025-04
    Posted
    Registry
    NCT07692750

    Age 18 years to Not stated (registered criteria)

    Led by Zhejiang Cancer HospitalHangzhou

  18. Recruiting
    Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy
    Phase
    Phase 3
    Started
    2025-07
    Posted
    Registry
    NCT07823049

    Age not stated (registered criteria)

    Lead sponsor is not a listed hospital; 36 listed hospitals as study sitesBeijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Nanchang, Nanjing, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Xi'an, Yangzhou, Yinchuan, Zhengzhou

  19. Recruiting
    A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
    Phase
    Phase 2/Phase 3
    Started
    2024-05
    Posted
    Registry
    NCT06361888

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 41 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Jinan, Kunming, Linyi, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shenzhen, Suzhou, Tianjin, Wenzhou, Wuhan, Xi'an, Xiamen, Zhengzhou

  20. Recruiting
    Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
    Phase
    Phase 2
    Started
    2024-07
    Posted
    Registry
    NCT06534762

    Age 18 years to 65 years (registered criteria)

    Led by Zhejiang Provincial People's HospitalHangzhou

  21. Recruiting
    Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer
    Phase
    Phase 1/Phase 2
    Started
    2024-11
    Posted
    Registry
    NCT06572813

    Age 18 years to 75 years (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  22. Recruiting
    Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
    Phase
    Phase 2
    Started
    2024-11
    Posted
    Registry
    NCT06722911

    Age 18 years to 75 years (registered criteria)

    Led by Zhejiang Provincial People's HospitalHangzhou

  23. Recruiting
    Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
    Phase
    Phase 1
    Started
    2024-07
    Posted
    Registry
    NCT06821048

    Age 18 years to Not stated (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  24. Recruiting
    A Study of JMT203 in Patients With Cancer Cachexia
    Phase
    Phase 1/Phase 2
    Started
    2024-05
    Posted
    Registry
    NCT06868849

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteHangzhou

  25. Recruiting
    CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
    Phase
    Early phase 1
    Started
    2024-12
    Posted
    Registry
    NCT06937567

    Age 18 years to 70 years (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  26. Recruiting
    A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
    Phase
    Phase 2
    Started
    2023-05
    Posted
    Registry
    NCT05859750

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 7 listed hospitals as study sitesBeijing, Guangzhou, Hangzhou, Jinan, Shanghai, Wuhan

  27. Recruiting
    A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
    Phase
    Phase 1
    Started
    2023-07
    Posted
    Registry
    NCT05911217

    Age 18 years to 79 years (registered criteria)

    Lead sponsor is not a listed hospital; 8 listed hospitals as study sitesBeijing, Changsha, Hangzhou, Shanghai, Wuhan, Xi'an, Zhengzhou

  28. Recruiting
    A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.
    Phase
    Phase 2
    Started
    2023-10
    Posted
    Registry
    NCT06008288

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 29 listed hospitals as study sitesBeijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Nanchang, Nanjing, Qingdao, Shanghai, Shenyang, Tianjin, Wuhan, Xi'an, Zhengzhou

  29. Recruiting
    A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
    Phase
    Phase 1
    Started
    2023-08
    Posted
    Registry
    NCT06043466

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesHangzhou

  30. Recruiting
    Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
    Phase
    Not given
    Started
    2023-11
    Posted
    Registry
    NCT06139042

    Age 40 years to 75 years (registered criteria)

    Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou

  31. Recruiting
    Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery
    Phase
    N/A
    Started
    2023-03
    Posted
    Registry
    NCT06164769

    Age 14 years to 70 years (registered criteria)

    Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou

  32. Recruiting
    Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
    Phase
    Phase 1/Phase 2
    Started
    2023-12
    Posted
    Registry
    NCT06799637

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou, Hefei, Kunming, Luoyang, Shanghai, Wuhan

  33. Recruiting
    A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
    Phase
    Phase 1
    Started
    2022-06
    Posted
    Registry
    NCT05365581

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 5 listed hospitals as study sitesGuangzhou, Hangzhou, Shanghai, Wuhan, Zhengzhou

  34. Recruiting
    Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
    Phase
    Not given
    Started
    2022-09
    Posted
    Registry
    NCT06822413

    Age not stated (registered criteria)

    Led by Second Affiliated Hospital, Zhejiang University; 3 listed hospitals as study sitesHangzhou, Nanchang, Shanghai

  35. Recruiting
    Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
    Phase
    Phase 1
    Started
    2021-06
    Posted
    Registry
    NCT04900818

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 10 listed hospitals as study sitesBeijing, Guangzhou, Hangzhou, Harbin, Hefei, Shanghai, Shenyang, Tianjin, Wuhan, Zhengzhou

  36. Recruiting
    Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer
    Phase
    Phase 2
    Started
    2018-04
    Posted
    Registry
    NCT03498326

    Age 18 years to 90 years (registered criteria)

    Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou

  37. Not yet recruiting
    IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
    Phase
    Phase 2
    Started
    2026-02
    Posted
    Registry
    NCT07415525

    Age 18 years to 75 years (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  38. Not yet recruiting
    Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors
    Phase
    Phase 1
    Started
    2026-07
    Posted
    Registry
    NCT07624214

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteHangzhou

  39. Not yet recruiting
    Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in Solid Tumors With Liver Metastases
    Phase
    Phase 2
    Started
    2026-10
    Posted
    Registry
    NCT07875465

    Age 18 years to Not stated (registered criteria)

    Led by Hangzhou Cancer HospitalHangzhou

  40. Not yet recruiting
    Phase 1 Study of NW-301V TCR-T Cells in Advanced Solid Tumors With KRAS G12V Mutation
    Phase
    Phase 1
    Started
    2026-10
    Posted
    Registry
    NCT07875920

    Age 18 years to 75 years (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteHangzhou

  41. Not yet recruiting
    Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer
    Phase
    Phase 2
    Started
    2025-01
    Posted
    Registry
    NCT06759090

    Age 18 years to Not stated (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  42. Not yet recruiting
    Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.
    Phase
    Phase 1/Phase 2
    Started
    2025-04
    Posted
    Registry
    NCT06888648

    Age 18 years to 75 years (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  43. Not yet recruiting
    Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.
    Phase
    Phase 1/Phase 2
    Started
    2025-04
    Posted
    Registry
    NCT06888674

    Age 18 years to 75 years (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  44. Not yet recruiting
    Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy
    Phase
    N/A
    Started
    2025-05
    Posted
    Registry
    NCT06960122

    Age 18 years to Not stated (registered criteria)

    Led by Second Affiliated Hospital, Zhejiang UniversityHangzhou

  45. Not yet recruiting
    Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures
    Phase
    Not given
    Started
    2024-08
    Posted
    Registry
    NCT06495749

    Age not stated (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  46. Not yet recruiting
    Research of the Application of Artificial Intelligence Model "PANDA"
    Phase
    N/A
    Started
    2024-08
    Posted
    Registry
    NCT06528223

    Age not stated (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  47. Not yet recruiting
    Canagliflozin With Gemcitabine in Pancreatic Carcinoma
    Phase
    N/A
    Started
    2023-10
    Posted
    Registry
    NCT05903703

    Age 18 years to Not stated (registered criteria)

    Led by Hangzhou First People's HospitalHangzhou

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

Disease research in Hangzhou

Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.

A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.

Papers led and open trials led by hospitals in Hangzhou, by disease
CancerBlood disordersOther diseases
HospitalNasopharyngeal carcinomaOesophageal squamous cell carcinomaHepatocellular carcinomaStomach cancerLung cancerPancreatic cancerBreast cancerGliomaHepatoblastomaRetinoblastomaChordomaOsteosarcomaGastrointestinal stromal tumourNeuroblastomaEwing sarcomaMultiple myelomaB-cell acute lymphoblastic leukaemiaAplastic anaemiaHaemophagocytic lymphohistiocytosisLymphomaBeta thalassaemiaHaemophilia AAtypical haemolytic uraemic syndromeThrombotic thrombocytopenic purpuraFanconi anaemiaNeuromyelitis optica spectrum disorderIgG4-related diseaseMyasthenia gravisMoyamoya diseaseWilson diseaseBiliary atresiaCoronary heart diseaseCongenital heart diseaseScoliosisAnti-NMDA receptor encephalitisTakayasu arteritisHepatic echinococcosisIdiopathic pulmonary fibrosisLymphangioleiomyomatosisAmyotrophic lateral sclerosisSpinal muscular atrophyFabry diseasePompe diseaseDuchenne muscular dystrophyBehçet diseaseAlport syndromeIgA nephropathyGaucher diseaseNiemann–Pick disease type COsteogenesis imperfectaPrimary biliary cholangitisPrimary sclerosing cholangitisCongenital diaphragmatic herniaHirschsprung diseaseInherited epidermolysis bullosaHereditary angioedemaFamilial adenomatous polyposisLeber hereditary optic neuropathyMajeed syndromeNGLY1 deficiencyISG15 deficiencyShortlist
Affiliated Hospital of Hangzhou Normal University杭州师范大学附属医院nonenonenonenonenonenonenonenonenonenonenone0nonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenone2none4nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenone
Children's Hospital, Zhejiang University School of Medicine浙江大学医学院附属儿童医院nonenonenonenonenonenonenone81 open1nonenone5none7nonenone52841 opennone0none1nonenonenone11 opennonenone23313 open4nonenonenonenonenone1221 opennone0none074 opennone0nonenonenone04nonenonenone41nonenone
Chun'an First People's Hospital淳安县第一人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
First Affiliated Hospital of Zhejiang Chinese Medical University浙江中医药大学附属第一医院(浙江省中医院)nonenonenone2950none49nonenonenonenone21nonenone2none241 opennone8none24none1nonenonenone4nonenonenone2none33 open1nonenone1none1none1nonenone2none2nonenonenone0nonenonenonenonenonenonenonenonenonenone
First Affiliated Hospital, Chinese Medical University浙江中医药大学附属第一医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
First Affiliated Hospital, Zhejiang University浙江大学医学院附属第一医院5112588 open6514 open1272 open11514 open6412 open32none1none891 open51 open0556 open513 open11 open146711 opennone411none3201 opennone41 open22117none4104none5none2none020201 open1144none1nonenone0nonenonenonenone
Fourth Affiliated Hospital of Zhejiang University浙江大学医学院附属第四医院nonenone6none93 opennonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone2nonenonenonenonenone0nonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenone4nonenonenone
Fourth Affiliated Hospital, Zhejiang Universitynonenonenonenonenone6nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Hangzhou Cancer Hospital杭州市肿瘤医院14nonenone131 open11 opennonenonenone1none0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Hangzhou Children's Hospital杭州市儿童医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Hangzhou First People's Hospital杭州市第一人民医院8none671151231 open218none1none31nonenone5nonenonenone7nonenonenonenonenonenonenonenonenonenonenone161nonenonenonenone1none2none1none11none0nonenonenone1nonenonenonenonenonenone0nonenonenone
Hangzhou Fuyang District First People's Hospital杭州市富阳区第一人民医院nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Hangzhou Hospital, Zhejiang Chinese Medicine Universitynonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Hangzhou Lin'an Traditional Chinese Medicine Hospital杭州市临安区中医院nonenonenonenonenonenonenonenonenonenonenone1nonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Hangzhou Linping District First People's Hospital杭州市临平区第一人民医院nonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Hangzhou Red Cross Hospital杭州市红十字会医院nonenonenonenonenonenonenonenonenonenonenonenone11nonenonenonenonenonenonenonenonenonenonenone2nonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Hangzhou TCM Hospital, Zhejiang Chinese Medical University杭州市中医院nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone114nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Hangzhou Third People's Hospital杭州市第三人民医院nonenonenonenonenonenonenonenonenonenonenone3nonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Hangzhou Women's Hospital杭州市妇科医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone3nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Hangzhou Xixi Hospital杭州市西溪医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone51nonenonenonenonenonenonenonenonenone
Jianggan District People's Hospital杭州市江干区人民医院nonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Second Affiliated Hospital of Zhejiang Chinese Medical University浙江中医药大学附属第二医院(浙江省新华医院)nonenonenonenonenonenonenonenonenonenonenone13none1nonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone11nonenonenonenonenonenonenonenonenone
Second Affiliated Hospital, Zhejiang University浙江大学医学院附属第二医院143 open689 open596 open11512 open665 open10931 open419 opennone101653052 opennonenone24320 opennonenonenone1none7none41282 opennone368 open9540none4none6none001012nonenone0nonenone11none140nonenonenone
Shaoxing People's Hospital绍兴市人民医院nonenonenone14297none9nonenonenone2none1none0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone3nonenonenonenonenonenone1nonenone2nonenonenonenonenonenonenonenonenonenonenonenonenone
Shulan Hangzhou Hospital树兰(杭州)医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenone
Sir Run Run Shaw Hospital浙江大学医学院附属邵逸夫医院41833 open44831 open29491 open15nonenonenone102nonenone4nonenonenone7nonenonenone1nonenone30nonenonenone232 open11nonenone1none010nonenone0none1none3none0none10nonenonenonenonenonenonenonenonenone
Third Affiliated Hospital of Zhejiang Chinese Medical University浙江中医药大学附属第三医院(浙江省中山医院)nonenonenonenonenonenonenone2nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone4nonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Tongde Hospital浙江省立同德医院0nonenone20nonenonenonenonenonenonenone08nonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Women's Hospital浙江大学医学院附属妇产科医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone6nonenonenonenonenonenone0nonenonenone0nonenonenonenonenonenonenonenone1nonenonenonenone1nonenonenone
Xiaoshan Traditional Chinese Medical Hospital杭州市萧山区中医院nonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Zhejiang Cancer Hospital浙江省肿瘤医院196 open506 open353 open10611 open2047 open232 open11015 open180nonenone200none2none22137 opennonenonenonenone2nonenonenonenonenonenonenonenonenonenonenonenone1none1nonenonenone1nonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenone
Zhejiang Hospital浙江医院nonenonenonenone31none6nonenonenonenone02nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone90none1nonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Zhejiang Hospital浙江医院nonenonenonenonenonenone01 opennonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone02 opennonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Zhejiang Provincial People's Hospital浙江省人民医院4411938691 open533 open741 open241 opennone0none401010nonenonenone151 opennonenonenonenonenonenonenone2nonenonenone1253nonenonenone1none1none1none00none4nonenonenone42nonenonenonenonenonenonenonenonenone

Column labels are short names. Choose one to open that disease in Hangzhou.

Other cities nearby

Straight-line distance from the city centre; counts are hospitals listed for pancreatic cancer.

Counts are listed hospitals only, not every hospital in each city.

Where these numbers come from

Papers

English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions

Trials

ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Hangzhou on ClinicalTrials.gov

Locations

Locations are shown at city centres. Check the hospital’s website for its address.

Suggest a correctionDownload the data